We are live on
!
Find out more
GA
Geneva Advisors Portfolio holdings
AUM
$5.81B
Turnover
22.5%
1-Year Est. Return
23.71%
This Fund
S&P 500
This Quarter
Est. Return
+5.3%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.53B
AUM Growth
+$159M
(+3%)
Cap. Flow
-$12.4M
Cap. Flow
% of AUM
-0.22%
Top 10 Holdings %
Top 10 Hldgs %
20.92%
Holding
797
New
64
Increased
251
Reduced
262
Closed
82
Avg Time Held
1.1
years
Top 10 Avg Time Held
0.7
years
Top 20 Avg Time Held
0.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ulta Beauty
ULTA
|
+$42M |
| 2 |
CF Industries
CF
|
+$41.4M |
| 3 |
BEAV
B/E Aerospace Inc
BEAV
|
+$36.2M |
| 4 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$33.3M |
| 5 |
Sunoco
SUN
|
+$29.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$55.7M |
| 2 |
ITC
ITC HOLDINGS CORP
ITC
|
+$38.9M |
| 3 |
AGN
Allergan Inc
AGN
|
+$38.3M |
| 4 |
Accenture
ACN
|
+$37.2M |
| 5 |
Tesla
TSLA
|
+$35.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.43% |
| 2 | Financials | 16.55% |
| 3 | Consumer Discretionary | 12.19% |
| 4 | Industrials | 12.01% |
| 5 | Technology | 10.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
126
Qualcomm
QCOM
$191B
| $5.63M | 0.1% |
81,123
-4,718
| -5% | -$332K |
2013 Q2
7 quarters
|
|
127
Costco
COST
$433B
| $5.53M | 0.1% |
36,526
+1,102
| +3% | +$162K |
2013 Q2
7 quarters
|
|
128
Genesis Energy
GEL
$1.7B
| $5.34M | 0.1% |
113,620
+3,695
| +3% | +$164K |
2013 Q2
7 quarters
|
|
129
Chubb
CB
$136B
| $5.28M | 0.1% |
47,369
-2,372
| -5% | -$267K |
2013 Q2
7 quarters
|
|
130
Illinois Tool Works
ITW
$77.2B
| $5.05M | 0.09% |
52,007
+4,162
| +9% | +$401K |
2013 Q2
7 quarters
|
|
131
Alibaba
BABA
$276B
| $5.03M | 0.09% |
60,478
-391,123
| -87% | -$35.3M |
2014 Q3
2 quarters
|
|
132
McDonald's
MCD
$172B
| $4.95M | 0.09% |
50,793
-5,604
| -10% | -$532K |
2013 Q2
7 quarters
|
|
133
PepsiCo
PEP
$175B
| $4.92M | 0.09% |
51,477
+1,185
| +2% | +$115K |
2013 Q2
7 quarters
|
|
134
Dollar General
DG
$29.5B
| $4.63M | 0.08% |
61,468
-2,815
| -4% | -$199K |
2014 Q1
4 quarters
|
|
135
RTX Corp
RTX
$252B
| $4.59M | 0.08% |
62,238
-1,104
| -2% | -$82.5K |
2013 Q2
7 quarters
|
|
136
State Street SPDR S&P 500 ETF Trust
SPY
$815B
| $4.49M | 0.08% |
21,767
-6,860
| -24% | -$1.42M |
2013 Q2
7 quarters
|
|
137
MarketAxess Holdings
MKTX
$5.79B
| $4.49M | 0.08% |
54,150
+250
| +0.5% | +$19.8K |
2013 Q2
7 quarters
|
|
138
Manhattan Associates
MANH
$13.2B
| $4.42M | 0.08% |
87,260
-3,580
| -4% | -$173K |
2013 Q3
6 quarters
|
|
139
PPG Industries
PPG
$24B
| $4.32M | 0.08% |
38,270
+492
| +1% | +$56.4K |
2014 Q4
1 quarter
|
|
140
Novo Nordisk
NVO
$173B
| $4.29M | 0.08% |
160,526
+31,500
| +24% | +$725K |
2014 Q2
3 quarters
|
|
141
ASML
ASML
$637B
| $4.25M | 0.08% |
42,018
-1,804
| -4% | -$190K |
2014 Q1
4 quarters
|
|
142
Abbott
ABT
$181B
| $4.22M | 0.08% |
91,030
-1,515
| -2% | -$69.6K |
2013 Q2
7 quarters
|
|
|
MDVN
143
DELISTED
MEDIVATION, INC.
MDVN
| $4.17M | 0.08% |
64,640
+25,850
| +67% | +$1.48M |
2014 Q3
2 quarters
|
|
144
IBM
IBM
$221B
| $4.11M | 0.07% |
26,792
-3,772
| -12% | -$572K |
2013 Q2
7 quarters
|
|
145
DELISTED
Western Gas Partners Lp
WES
| $4.08M | 0.07% |
62,037
-845
| -1% | -$58.4K |
2013 Q2
7 quarters
|
|
146
iShares MSCI EAFE ETF
EFA
$76.9B
| $4.02M | 0.07% |
62,685
+5,135
| +9% | +$323K |
2013 Q2
7 quarters
|
|
147
Tortoise Energy Infrastructure Corp
TYG
$976M
| $3.93M | 0.07% |
23,393
-1,013
| -4% | -$175K |
2013 Q4
5 quarters
|
|
|
TTM
148
DELISTED
Tata Motors Limited
TTM
| $3.91M | 0.07% |
86,709
-17,777
| -17% | -$838K |
2014 Q1
4 quarters
|
|
149
BioMarin Pharmaceuticals
BMRN
$10.8B
| $3.81M | 0.07% |
30,532
+7,310
| +31% | +$775K |
2013 Q2
7 quarters
|
|
150
AerCap
AER
$22.9B
| $3.79M | 0.07% |
86,857
+18,694
| +27% | +$788K |
2014 Q3
2 quarters
|
|
Similar funds
CAM
DL
TCM
HCM
AL
AT
Geneva Advisors's Q1 2015 Portfolio in Review
As of Q1 2015, Geneva Advisors held 797 positions worth $5.53B, up 3% from $5.37B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Geneva Advisors's Q1 2015 filing shows 64 new, 251 increased, 262 reduced and 82 closed positions. Its largest new stake was Ulta Beauty: 303,437 shares worth $45.8M. The largest sale was Johnson & Johnson, an estimated $55.7M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
- Geneva Advisors's largest Q1 2015 buy was Ulta Beauty: 303,437 shares worth $45.8M.
- Geneva Advisors added most to CF Industries in Q1 2015, an estimated $41.4M increase.
- Geneva Advisors's biggest Q1 2015 reduction was Johnson & Johnson, cutting an estimated $55.7M.
- Geneva Advisors fully exited Allergan Inc in Q1 2015, selling an estimated $38.3M.
- Geneva Advisors's ten largest holdings make up 21% of its $5.53B portfolio in Q1 2015.
- Geneva Advisors opened 64 new positions and closed 82 in Q1 2015.
- Geneva Advisors's portfolio value rose 3% quarter-over-quarter to $5.53B.
Based on Geneva Advisors's 13F filing for Q1 2015, filed 5 May 2015.